Position in CYTK
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$22,745
New position
Shares Held
267
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#398
of 477 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026V-Square Quantitative Management LLC holds $6,143,388 across 14 Biotechnology names. CYTK ranks #13 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,531 | $2,747,413 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,211 | $665,577 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,025 | $639,128 | |
| 4 | INCY |
Incyte Corp
|
5,417 | $614,071 | |
| 5 | MRNA |
Moderna, Inc.
|
6,532 | $457,435 | |
| 6 | TECH |
BIO-TECHNE Corp
|
6,197 | $437,818 | |
| 7 | RPRX |
Royalty Pharma plc
|
6,318 | $354,250 | |
| 8 | EXEL |
Exelixis, Inc.
|
1,037 | $56,423 |
All Filings in CYTK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,745 | 267 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||